Quantcast

Latest Pre-exposure prophylaxis Stories

2010-07-19 13:55:00

VIENNA, July 19 /PRNewswire-USNewswire/ -- "This is a historic day for HIV prevention research. The CAPRISA 004 results are the first clinical evidence that a microbicide gel can help to prevent sexual transmission of HIV infection," said AVAC Executive Director Mitchell Warren, reacting to the results of the landmark microbicide trial presented today at the International AIDS Conference in Vienna. "We believe that the most responsible plan of action now is to quickly and efficiently...

2010-06-15 12:37:00

RESEARCH TRIANGLE PARK, N.C., June 15 /PRNewswire-FirstCall/ -- Talecris Biotherapeutics announced today that it has agreed to a co-promotion arrangement with Novartis Vaccines to jointly market and sell their respective post-exposure rabies products. Talecris provides HyperRAB® S/D (Rabies Immune Globulin [Human]), an essential component of rabies post-exposure prophylaxis for previously unvaccinated individuals, that is administered in combination with rabies...

2010-05-24 13:19:33

New research presented at International Microbicides Conference Their scientific methods may have been quite different, but their conclusions were not. In asking whether drug resistance could be a problem if antiretroviral (ARV) drugs become a mainstay for HIV prevention, the two studies "“ one involving a mathematical model and the other assays of cells and tissue "“ arrived at the same answer. Resistance could happen if people who are unknowingly already infected use the...

2010-03-30 09:10:29

"The value of animal experiments for predicting the effectiveness of treatment strategies in clinical trials has remained controversial, mainly because of a recurrent failure of interventions apparently promising in animal models to translate to the clinic," say authors in a Research in Translation piece published in PLoS Medicine this week. The PLoS Medicine magazine article by H. van der Worp (University Medicine Centre Utrecht) and colleagues discusses the controversies and possibilities...

2010-02-26 10:00:27

Women given the human immunodeficiency virus (HIV) prevention drug nevirapine to protect their fetus should not use an HIV-drug regimen that contains nevirapine for at least one year after childbirth, say researchers at the University of Alabama at Birmingham (UAB). A new UAB study found that while nevirapine works well to prevent mother-to-child HIV transmission, a single dose of nevirapine in infected pregnant women can trigger resistance to some forms of the AIDS-drug cocktail known as...

2010-01-21 13:27:20

Systemic pre-exposure administration of antiretroviral drugs provides protection against intravenous and rectal transmission of HIV in mice with human immune systems, according to a new study published January 21, 2010 in the online journal PLoS ONE. "These results provide evidence that a universal approach to prevent all forms of HIV transmission in all settings might be possible," said J. Victor Garcia-Martinez, Ph.D., professor in the department of medicine at the University of North...

2009-12-14 01:25:00

Funding and Support for HIV Prevention Research Must Continue NEW YORK, Dec. 14 /PRNewswire-USNewswire/ -- The Microbicides Development Programme announced earlier today that its MDP 301 effectiveness trial, which was conducted among almost 9,400 women in four African countries, found no evidence that the PRO 2000 microbicide reduces the risk of HIV infection. Reacting to today's announcement, AVAC executive director Mitchell Warren said, "Of course, we are disappointed to hear these...

2009-05-17 23:00:00

AVAC Report Assesses Progress in AIDS Vaccine, Microbicide and PrEP Research and Calls for Urgent Coordination and Leadership in Advance of Upcoming Results NEW YORK, May 18 /PRNewswire-USNewswire/ -- "It's an exciting time in HIV prevention research. We will see results from a number of critically important HIV prevention research trials this year, as well as see the start of new trials around the world that will yield important answers in the years to come," said Mitchell Warren, AVAC...

2009-04-28 09:50:10

A new study, carried out in primary care units in Zanzibar and published in this week's issue of PLoS Medicine, evaluates the impact of rapid malaria tests on prescribing practice and clinical outcomes. The findings suggest that routine use of such tests may reduce the number of people who are inappropriately given antimalarial drugs. Currently, malaria in sub-Saharan Africa tends to be diagnosed on the basis of symptoms alone (i.e. fever). However, such symptoms are not very accurate and...

032ef8e996572fdacb37eec22814c13f1
2008-11-19 15:45:00

An experimental strategy called pre-exposure prophylaxis, or PrEP, may lower the risk of catching HIV in sexual active people who do not use protection. PrEP is currently being tested in several large trials, with the first results due next year. Pending positive results, the drug could save millions of lives from the HIV epidemic that infects an estimated 7000 people every day. But many critics fear that it may provide people a false sense of security, encouraging them to have more unsafe...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'